Thursday, December 8, 2011
Gene test that could help predict DCIS outcomes
According to the San Antonio Breast Cancer Symposium, a new gene test could help predict the severity of a type of breast cancer called ductal carcinoma in situ, also known DCIS. The gene test consists of looking at 12 genes of the woman's tumor. From the test, professionals could tell how severe the cancer is. It could predict if the cancer will need need surgery and radiation or just surgery. This could spare the patient from getting unnecessary radiation. Even though some experts say that that radiation is somewhat safe, sometimes it could put people's heart and lung tissue at risk. This test is also help people save thousands of dollars. Even though the test will cost around $4,175, it is cheaper than getting radiation therapy, which will cost around $20,000. More than 45,000 women in the U.S. are diagnosed with this type of cancer, but it could save some women from receiving radiation.
I think that this test will be very benefial to women that are diagnosed with DCIS. It could save people thousands of dollars by not receiving unnecessary radiation. Even though radiation is somewhat safe, avoiding radiation treatment is better for the body.